Bailard’s Viridian Therapeutics VRDN Stock Holding History

Bailard’s Portfolio VRDN Stock Details VRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-90,500	Closed	-$1.66M	–	769
2021 Q2	$1.66M	Sell	90,500 -20,500	-18%	-$351K	0.06%	221
2021 Q1	$1.85M	Buy	+111,000	New	+$2.08M	0.07%	209

Other funds holding VRDN

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Bailard's VRDN Position: Q3 2021 in Review

Bailard sold out of Viridian Therapeutics (VRDN) in Q3 2021, closing a stake of 90,500 shares — an estimated $1.66M sold.

Bailard first reported a position in VRDN in Q1 2021 and held it in 2 quarters. The position peaked at $1.85M in Q1 2021. 39 funds tracked by Wall St. Rank hold VRDN as of Q3 2021.

Bailard reported no remaining Viridian Therapeutics position as of Q3 2021 after selling out during the quarter.
Bailard sold 90,500 Viridian Therapeutics shares in Q3 2021, an estimated $1.66M.
Bailard first reported a position in Viridian Therapeutics in Q1 2021 and held it in 2 quarters.
Bailard's Viridian Therapeutics position peaked at $1.85M in Q1 2021.
39 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q3 2021.

Based on Bailard's 13F filing for Q3 2021, filed 15 Nov 2021.